Q&A Updated Following Changes to DPC Short-Stay Surgery Basic Fee 3 and Re

News Highlights

The sixth set of interpretations of doubts regarding the FY2026 medical fee revision has been released, announcing changes to the handling of DPC Short-Stay Surgery Basic Fee 3 and re-transfers for the same diagnosis. These changes require medical institutions to comply with new requirements for post-operative patient management and transfer decisions. This revision is expected to promote appropriate hospitalization periods and the development of a more efficient healthcare delivery system.

M&A Medical Editorial Department’s Perspective

This interpretation of doubts specifies revisions to the eligibility criteria for Short-Stay Surgery Basic Fee 3 under the DPC system and changes in the handling of re-transfers for the same diagnosis. For medical institutions considering transitions to broader collaborative structures like regional healthcare cooperation promotion corporations or specific medical corporations, this is more than just a change in fee calculation rules. For example, if the eligibility criteria for Short-Stay Surgery Basic Fee 3 become stricter, small and medium-sized hospitals that have relied on meeting these criteria for revenue may be forced to reconsider their revenue structures. Strategies such as group affiliation or collaboration to maintain facility standards and distribute the burden of capital investment could become more viable options. Furthermore, when considering a transition to a specific medical corporation or social medical corporation, these medical fee revision trends are crucial factors that will influence future profitability and the feasibility of business plans. The FY2026 revision will likely serve as an impetus not only for single-year revenue improvement but also for the restructuring of mid-to-long-term management and succession strategies.

Points Raised by This News

• Impact of changes to eligibility criteria for Short-Stay Surgery Basic Fee 3 on the revenue structure of small and medium-sized hospitals
• Impact of new rules regarding re-transfers for the same diagnosis on strategies for utilizing bed functions
• Importance of revision details when considering transitions to regional healthcare cooperation promotion corporations or specific medical corporations
• Potential for the FY2026 revision to accelerate the grouping and collaboration of medical institutions

Practical Questions Arising from This News

• What specific surgeries will be affected by the changes to Short-Stay Surgery Basic Fee 3?
• What measures can be considered when re-transfers for the same diagnosis are not permitted?
• How can the impact of this medical fee revision be mitigated through grouping or collaboration?

If You Feel “Should I Consult Too?”

If you are concerned that this medical fee revision, particularly the changes in handling DPC Short-Stay Surgery Basic Fee 3 and re-transfers, will affect your institution’s revenue structure or bed function utilization strategy, it is necessary to consider it from the perspective of M&A and business succession. Through collaboration with experts, you can identify pathways to maximize your institution’s management resources, such as enjoying economies of scale through group affiliation, strategies for maintaining facility standards, or optimizing tax schemes with a view to future corporate status transitions. Early consultation is key to broadening your future options.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultations are available here.